Kevin Kelnar

This inventor holds 20 USPTO granted patents and 23 published patent applications, plus 1 CIPO patent and 17 EPO patents, primarily in MiRNA Modulation. Top assignees: Asuragen, Inc., Mirna Therapeutics, Inc., Johns Hopkins University. Active years: 2011-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Kelnar. Retrieved from https://idiyas.com/inventor/kevin-kelnar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 23)

% Patents Active = 5.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 17 (Patent Applications = 28)

Average Co-Inventor Count = 4.6

ph-index = 9

Forward Citations = 346(Granted Patents)

Company Filing History:

Mirna Therapeutics, Inc.

patents

2 out of 3,806

Johns Hopkins University

patents

4. 1 out of 1

Mima Therapeutics, Inc

patent

where one patent can have more than one assignee

Years Active: 2011-2017

Loading Chart...

Areas of Expertise:

miRNA

Angiogenesis

Neovascularization

Biomarkers

Therapeutic Intervention

Synthetic Mimics

miR-124

miR-34

Inhibitor Molecules

Prostate Disease

Compositions

Methods

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9611478 - Synthetic mimics of miR-124 (2017-04-04),

2. 9540645 - Compositions and methods related to miRNA modulation of neovascularization or angiogenesis (2017-01-10),

3. 9506061 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2016-11-29),

4. 9447414 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2016-09-20),

5. 9382537 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2016-07-05),

6. 9371526 - Synthetic mimics of miR-34 (2016-06-21),

7. 9365852 - Compositions and methods related to miRNA modulation of neovascularization or angiogenesis (2016-06-14),

8. 9222085 - Synthetic mimics of MIR-124 (2015-12-29),

9. 9068219 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2015-06-30),

10. 9051571 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2015-06-09),

11. 8946177 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2015-02-03),

12. 8765709 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2014-07-01),

13. 8597892 - MiRNA biomarkers of prostate disease (2013-12-03),

14. 8586727 - Synthetic mimics of miR-34 (2013-11-19),

15. 8563708 - Methods and compositions involving miRNA and miRNA inhibitor molecules (2013-10-22),

Title: Inventor Kevin Kelnar - Pioneering Innovations in Kyle, TX

Introduction: Kevin Kelnar is a visionary inventor based in Kyle, Texas, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Kevin Kelnar holds several patents in various industries, including telecommunications, renewable energy, and consumer electronics. His most recent patent focuses on enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Kevin Kelnar has worked with leading tech companies to develop cutting-edge solutions. His work has been instrumental in shaping the future of digital communication and sustainable energy practices.

Collaborations: Throughout his career, Kevin Kelnar has collaborated with top researchers, engineers, and designers to bring his ideas to life. His collaborative spirit has led to the successful implementation of innovative technologies in real-world applications.

Conclusion: Kevin Kelnar's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on various industries is undeniable, making him a true pioneer in the world of technology.

Profile summary based on public USPTO records.